9 reports

  • Market trends
  • Key vendor analysis

Less number of approved therapies and huge costs associated with the treatment remains one of the significant challenges to this market.

  • Blood Disease
  • Medical Biotechnology
  • Protein Therapy
  • Therapy
  • CSL Behring GmbH
  • MARKET OVERVIEW

Impact ## Low; ## High Privigen is the first and only ##% IVIG therapy made with L-proline.

  • Therapy
  • Forecast
  • CSL Behring GmbH
  • Grifols, S.A.
  • Pfizer Inc.
  • Executive Summary
  • 3 Marketed Products

One case of nonserious rash and one case of myalgia were reported to be treatment-related.

  • Blood Disease
  • Protein Therapy
  • Therapy
  • Market Size
  • CSL Behring GmbH

Males have one X and one Y chromosome.

  • Therapy
  • North America
  • United States
  • World
  • CSL Behring GmbH
  • Competitive scenario
  • Key takeaway: Companies with a strong integration of marketing and R&D is likely to succeed

Strength: ## Low and ## High.

  • Blood Disease
  • Therapy
  • Baxalta Incorporated
  • CSL Behring GmbH
  • Novo Nordisk Group
  • Market drivers
  • Market landscape

You can easily book an appointment with one online.

  • Therapy
  • Baxalta Incorporated
  • CSL Behring GmbH
  • Grifols, S.A.
  • Kedrion S.p.A
  • Market drivers
  • Vendor landscape

However, only about one-third of this diseased population is diagnosed properly, or receives treatment.

  • Blood Disease
  • Therapy
  • Baxter International Inc.
  • Bayer AG
  • CSL Behring GmbH
  • 3.2 Information Sources

Albumin is used for the treatment of burns, shock, and hypovolemia; immunoglobulin for the treatment of primary immune deficiency and other immune disorders; alpha-## antitrypsin (AAT) for the treatment of alpha-## antitrypsin deficiency (AATD), and clottin

  • Therapy
  • Baxter International Inc.
  • CSL Behring GmbH
  • Grifols, S.A.
  • Octapharma AG
  • Vendor landscape
  • Market share analysis 2014

You can easily book an appointment with one online.

  • Therapy
  • Baxter International Inc.
  • CSL Behring GmbH
  • Grifols, S.A.
  • Octapharma AG